Manufacturer of Controlled Substances; Notice of Application, 2907 [E7-851]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 14 / Tuesday, January 23, 2007 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 21, 2006,
Cedarburg Pharmaceuticals, Inc., 870
Badger Circle, Grafton, Wisconsin
53024, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Remifentanil (9739) ......................
I
I
II
II
II
II
II
II
II
mstockstill on PROD1PC70 with NOTICES
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than March 26, 2007.
Dated: January 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–850 Filed 1–22–07; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
19:33 Jan 22, 2007
Jkt 211001
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 20,
2006, Organix Inc., 240 Salem Street,
Woburn, Massachusetts 01801, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
class of controlled substance listed in
schedule II.
The company plans on manufacturing
this controlled substance for sale to its
customers. These customers will sell the
drug in small quantities for research
purposes or as drug standards for
forensic laboratories.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than March 26, 2007.
Dated: January 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–851 Filed 1–22–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
National Institute of Corrections
Advisory Board Meeting
Time and Date: 8 a.m. to 4:30 p.m. on
Monday, February 26, 2007. 8 a.m. to
4:30 p.m. on Tuesday, February 27,
2007.
Place: American Correctional
Association, 206 North Washington
Street, Suite 200, Alexandria, Virginia
22314, 1 (800) 222–5646.
Status: Open.
Matters to be Considered: Reports;
Faith Based; Mental health; Prison Rape
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
2907
Elimination Act (PREA) Update; Agency
reports; Quarterly Report by Office of
Justice Programs.
Contact Person for More Information:
Larry Solomon, Deputy Director, 202–
307–3106, ext. 44254.
Morris L. Thigpen,
Director.
[FR Doc. 07–255 Filed 1–22–07; 8:45 am]
BILLING CODE 4410–30–M
NUCLEAR REGULATORY
COMMISSION
Agency Information Collection
Activities: Proposed Collection:
Comment Request
U.S. Nuclear Regulatory
Commission (NRC).
ACTION: Notice of pending NRC action to
submit an information collection
request to OMB and solicitation of
public comment.
AGENCY:
SUMMARY: The NRC is preparing a
submittal to OMB for review of
continued approval of information
collections under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
Information Pertaining to the
Requirement To Be Submitted
1. The title of the information
collection: NRC Form 314, Certificate of
Disposition of Materials.
2. Current OMB approval numbers:
3150–0028.
3. How often the collection is
required: The form is submitted once,
when a licensee terminates its license.
4. Who is required or asked to report:
Persons holding an NRC license for the
possession and use of radioactive
byproduct, source, or special nuclear
material who are ceasing licensed
activities and terminating the license.
5. The estimated number of annual
respondents: 171.
6. The number of hours needed
annually to complete the requirement or
request: 85.5.
7. Abstract: NRC Form 314 furnishes
information to NRC regarding transfer or
other disposition of radioactive material
by licensees who wish to terminate their
licenses. The information is used by
NRC as part of the basis for its
determination that the facility has been
cleared of radioactive material before
the facility is released for unrestricted
use.
Submit, by March 26, 2007, comments
that address the following questions:
1. Is the proposed collection of
information necessary for the NRC to
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 72, Number 14 (Tuesday, January 23, 2007)]
[Notices]
[Page 2907]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-851]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on September 20, 2006, Organix
Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application
by letter to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of Tetrahydrocannabinols (7370), a basic class
of controlled substance listed in schedule II.
The company plans on manufacturing this controlled substance for
sale to its customers. These customers will sell the drug in small
quantities for research purposes or as drug standards for forensic
laboratories.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than March 26, 2007.
Dated: January 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-851 Filed 1-22-07; 8:45 am]
BILLING CODE 4410-09-P
